"OncoCare Cancer Centre (Gleneagles) sees patients who are either suspected of having or are already diagnosed with cancer. We help them navigate the complexities of getting their diagnosis confirmed, understand the extent of disease and treatment options; be it surgery, chemotherapy, radiation therapy or combined therapies, and walk with them through their treatment journey. To date, OncoCare has grown to encompass 7 cancer centres comprising of specialists clinics with adjoining chemotherapy suites. The centres are designed around the patient, catering for comfort, privacy and efficiency when administering treatment."

During the past decade, OncoCare Cancer Centre- Gleneagles Medical Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "OncoCare Cancer Centre- Gleneagles Medical Centre" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "OncoCare Cancer Centre- Gleneagles Medical Centre" are "Non-Small Cell Lung Cancer Metastatic" (1 trials), "Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "OncoCare Cancer Centre- Gleneagles Medical Centre" in a lesser frequency.

Most popular intervention types in "OncoCare Cancer Centre- Gleneagles Medical Centre" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Gemcitabine" (1 trials) and "Patritumab Deruxtecan (Fixed dose)" (1 trials). Other intervention names were less common.

The vast majority of trials in "OncoCare Cancer Centre- Gleneagles Medical Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "OncoCare Cancer Centre- Gleneagles Medical Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in OncoCare Cancer Centre- Gleneagles Medical Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in OncoCare Cancer Centre- Gleneagles Medical Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".